% Ectoenzyme degrading angiotensin II thus forming angiotensin III.
Role in brain to control blood pressure. Regulator of blood vessel formation. APA deficient mice develop normally but fail to mount proper angiogenic response to hypoxia and growth factors.
Pyroglutamyl-peptidase II (EC 3.4.19.6) (TRH-Degrading AP, Thyrotropin-releasing hormone-degrading ectoenzyme) (Bauer 2004) 25 % Ectoenzyme that degrades and inactivates the neuropeptide thyrotropin releasing hormone. Thereby a potential regulator of thyrotropin and prolactin suggesting a role in e.g. control of body temperature and hart rate, stimulator of locomotor activity, effects on arousal and pain perception.
Puromycin sensitive aminopeptidase (EC 3.4.11.14) (ApPS, Cytosol alanyl aminopeptidase, Enkephalin-degrading AP) (Lendeckel et al., 2004, Thompson and Hersh 2004) 24 % Ectoenzyme inactivating enkephalins and other bioactive peptides.
Inolved in e.g. cell cycle regulation, apoptosis, protein turnover and antigen presentation. Broad tissue distribution. Knock-out Mice exhibit dwarfism, increased anxiety, and extended latency of pain reaction. Infertile male and female due to impaired spermatogenesis and inability to form corpus luteum, respectively.
Placental leucine aminopeptidase (EC 3.4.11.3) (Cystinyl AP, Oxytocinase, Insuline-responsive AP, IRAP) (Nomura et al., 2004) 25 % Ectoenzyme degrading oxytocin and vasopress-in, therby a putative regulator of labor and uterine contraction. Translocates to cell membrane in response to insulin in adipocytes and muscle cells.
Receptor of angiotensin IV in brain and thereby possibly involved in learning and memory. Knock-out mice appear normal, particularly no effect on labor.
Aminopeptidase B (EC 3.4.11.6) (Arginyl AP, RNPEP) (Cadel et al., 2004) 37 % Unknown biological function. Strictly removes basic residues. Broad tissue distribution.
Aminopeptidase PILS (Puromycin Insensitive Leucyl specific AP, Endoplasmatic Reticulum AP-1, ERAP-1) (Saric and Goldberg 2004) 22 % Processing of peptides for MHC Class I antigen presentation. Induced by interferon-γ. Broad tissue distribution with highest in e.g. spleen, thymus, liver, heart and placenta. AP PILS siRNA treatment of HeLa cells leads to increase of MHC Class I on cell surface.
RNPEP-like protein (Mername-AA050 peptidase) (Xiong et al., 2002) 33 % Differently expressed in immortalized human esophageal epithelial cell lines and malignant transformed esophageal carcinoma cell line.
Leukocyte-derived arginine aminopeptidase (L-RAP, ERAP-2, Mernam-AA066 peptidase, AP MAMS) (Tanioka et al., 2003) 23 % Membrane associated peptidase found on the lumenal side of ER. Induced by interferon-γ. Preference for arginyl-peptides. Expressed in most tissues with high levels in spleen and leukocytes.
Laeverin (Mername-AA009 protein, Mername-AA120 peptidase) (Fujiwara et al., 2004, Haas et al., The first column gives the enzyme name and EC number, if assigned, along with some common alternative names followed by selected references. Column two indicates sequence identity (%) with LTA4H according to a pair-wise blast alignment. In column three, the given biological roles are only examples and not meant.
